What Investors Don't Know: Communist China Could Profit Billions From The World "Going Green."
Who controls 80% of the works lithium supply (the most important metal for building EV batteries)? China! And if you're outraged by that fact, then you'll love hearing how this western company is fighting back…
See How This Lithium Play Could Explode
Andrew Booth, insider at AbCellera Biologics

Andrew Booth Insider Information

Andrew became AbCellera’s CFO in 2019 after spending nearly 4 years on the company’s Board of Directors. Prior to joining AbCellera, Andrew spent 10 years at STEMCELL Technologies where he held roles as the CFO and the Chief Commercial Officer. Before STEMCELL, Andrew spent 7 years at General Electric, ending by leading M&A/Business Development for GE Healthcare’s Europe, Middle East, and Africa business and GE Healthcare’s global Life Sciences business based in London. Andrew is Chairman for Precision Nanosystems and a Director at the National Board of Canadian Manufacturers and Exporters. He is also a former Director at the BC Tech Association, at Life Sciences BC and at Light Integra Inc. Andrew holds an MBA from INSEAD and a BASc in Engineering Physics from the University of British Columbia.

What is Andrew Booth's net worth?

The estimated net worth of Andrew Booth is at least $1.48 million as of May 12th, 2022. Mr. Booth owns 138,500 shares of AbCellera Biologics stock worth more than $1,476,410 as of June 30th. This net worth approximation does not reflect any other assets that Mr. Booth may own. Additionally, Mr. Booth receives a salary of $563,570.00 as CFO at AbCellera Biologics. Learn More about Andrew Booth's net worth.

How old is Andrew Booth?

Mr. Booth is currently 48 years old. There are 5 older executives and no younger executives at AbCellera Biologics. The oldest executive at AbCellera Biologics is Mr. Tryn T. Stimart Esq., J.D., Chief Legal Officer, Chief Compliance Officer & Corp. Sec., who is 52 years old. Learn More on Andrew Booth's age.

What is Andrew Booth's salary?

As the CFO of AbCellera Biologics Inc., Mr. Booth earns $563,570.00 per year. There are 2 executives that earn more than Mr. Booth. The highest earning executive at AbCellera Biologics is Dr. Carl L.G. Hansen Ph.D., CEO, Pres & Chairperson, who commands a salary of $616,660.00 per year. Learn More on Andrew Booth's salary.

How do I contact Andrew Booth?

The corporate mailing address for Mr. Booth and other AbCellera Biologics executives is , , . AbCellera Biologics can also be reached via phone at 604 559 9905 and via email at [email protected] Learn More on Andrew Booth's contact information.

Has Andrew Booth been buying or selling shares of AbCellera Biologics?

In the last ninety days, Andrew Booth has bought $492,150.00 in shares of AbCellera Biologics stock. As an example of a recent trade by , 0 shares of the business's stock in a transaction that occurred on Thursday, June 30th. Learn More on Andrew Booth's trading history.

Who are AbCellera Biologics' active insiders?

AbCellera Biologics' insider roster includes Andrew Booth (CFO), John Hamer (Director), Carl Hansen (CEO), Michael Hayden (Director), Veronique Lecault (COO), Andrew Lo (Director), and John Montalbano (Director). Learn More on AbCellera Biologics' active insiders.

Are insiders buying or selling shares of AbCellera Biologics?

During the last year, AbCellera Biologics insiders bought shares 12 times. They purchased a total of 2,423,115 shares worth more than $19,085,047.93. During the last year, insiders at the sold shares 1 times. They sold a total of 162,649 shares worth more than $2,756,900.55. The most recent insider tranaction occured on June, 13th when Major Shareholder Holdings Ltd. Thermopylae bought 54,915 shares worth more than $440,967.45. Insiders at AbCellera Biologics own 45.8 % of the company. Learn More about insider trades at AbCellera Biologics.

Information on this page was last updated on 6/13/2022.

Andrew Booth Insider Trading History at AbCellera Biologics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/12/2022Buy85,000$5.79$492,150.00138,500View SEC Filing Icon  
11/11/2021Buy53,500$14.74$788,590.00View SEC Filing Icon  
6/9/2021Sell1,200,000$25.50$30,600,000.00View SEC Filing Icon  
See Full Table

Andrew Booth Buying and Selling Activity at AbCellera Biologics

This chart shows Andrew Booth's buying and selling at AbCellera Biologics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AbCellera Biologics Company Overview

AbCellera Biologics logo
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: $10.66
Low: $9.94
High: $10.71

50 Day Range

MA: $8.24
Low: $5.72
High: $10.65

2 Week Range

Now: $10.66
Low: $5.42
High: $22.63

Volume

67,388 shs

Average Volume

2,323,706 shs

Market Capitalization

$3.03 billion

P/E Ratio

15.80

Dividend Yield

N/A

Beta

N/A
WARNING: White House Declares "National Lithium Emergency"
With the US dependent on China for the most critical resource, we use for our military, electric vehicles, and power grid...The US is facing a "National Lithium Emergency". They are pumping hundreds of millions into sparking our lithium production. And one domestic Lithium exploration company just staked 11,700 acres of mineral claims in Nevada...
Read This Report To See Why Investors Are Excited